- In November 2023, BD introduced the PIVO Pro, a groundbreaking needle-free blood collection device. It is the first to integrate seamlessly with both long-term and integrated peripheral IV catheters, including the Nexiva system, which now features the FDA-approved NearPort IV Access
- In October 2023, B. Braun Medical Inc. launched the Introcan Safety 2 IV Catheter, incorporating Multi-Access Blood Control to enhance passive needlestick prevention. The design is aimed at reducing clinicians' exposure to blood, minimizing the risk of bloodborne pathogen transmission during intravenous procedures
- In June 2023, Teleflex Incorporated secured two group purchasing agreements with Premier, Inc., enabling Premier members to access exclusive pricing and terms on Teleflex’s Central Venous and Arterial Vascular Access products
- In July 2022, B. Braun Medical Inc. unveiled its new Introcan Safety 2 IV Catheter featuring one-time blood control. This innovation is designed to improve IV access safety for clinicians by reducing the risk of needlestick injuries and blood exposure
- In May 2022, Access Vascular, Inc. (AVI) received FDA 510(k) clearance for its HydroPICC Dual-Lumen catheter. Built with the same proprietary hydrophilic biomaterial as AVI’s single-lumen HydroPICC and HydroMID® catheters, it demonstrated significant reductions in complications such as occlusions, Deep Vein Thrombosis, phlebitis, and catheter replacements in recent studies
